Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.
about
Zaleplon for insomniaZopiclone for insomniaZolpidem for insomniaThe lesser evil? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs' perspectivesInsomniaEffectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug AdministrationMagic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary careGPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics[High usage of zolpidem and zopiclone. Cross-sectional study using claims data]The societal costs of insomniaValerian for sleep: a systematic review and meta-analysis.NICE review: not nice for patients!The options available in cognitive behavioral therapy to prevent chronification of insomniaThe Stabilization of Amorphous Zopiclone in an Amorphous Solid DispersionEfficacy and safety of as-needed, post bedtime dosing with indiplon in insomnia patients with chronic difficulty maintaining sleep.Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cellsCommentary on a critique for the Journal of Psychopharmacology: NICE--excellence or eccentricity? Reflections on the z-drugs as hypnotics review.Management of insomnia: update and new approaches.A Discrete Choice Experiment to Elicit Patient Willingness to Pay for Attributes of Treatment-Induced Symptom Relief in Comorbid. InsomniaBenefits and risks of benzodiazepines and Z-drugs: comparison of perceptions of GPs and community pharmacists in Germany.Long-term sedative use among community-dwelling adults: a population-based analysis.The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.Why do GPs prescribe psychotropic drugs when they would rather provide alternative psychological interventions?Regional variations of private prescriptions for the non-benzodiazepine hypnotics zolpidem and zopiclone in Germany.Severe dependency on zolpidem in a patient with multiple sclerosis suffering from paraspasticity.Anxiolytic, hypnotic and sedative medication use in Australia.Sleep problems in general practice: a national survey of assessment and treatment routines of general practitioners in Norway.Abuse-related effects of subtype-selective GABAA receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats.Short-term treatment with hypnotic drugs for insomnia: going beyond the evidence.[Use of zolpidem and zopiclone on private prescriptions between 1993 and 2007].General practitioners' preferences for managing insomnia and opportunities for reducing hypnotic prescribing.
P2860
Q24200706-8CADA569-1B27-49C2-9D71-581E953B2855Q24200717-47FEB9F8-EB60-4B59-AD2E-22F9E66DCFAAQ24200727-2FFFB4BD-6147-4410-AACB-D78091B22547Q24601078-6583B702-FD31-4CAE-AD37-C371B919E563Q24632498-F4F81C25-1A20-41AF-9930-370ECA87D1F0Q24633044-961D9732-3CD5-4D83-9D88-DA98C01078F0Q24642656-4E9D01A2-A0BD-451E-8E9D-C60AFCC0F499Q24683948-250DB5E2-7582-43C5-A5F8-B7AB93D2B556Q31110419-5DC970C3-17CA-46DF-925F-3F9C462CCF4EQ34560329-E82951F4-652E-4B68-9C38-23EC751885B2Q35387048-D2EC0B0D-59A8-43EF-9C6D-BF76D2540938Q36053278-787AABC8-2D69-4625-A43E-4D701086FAF2Q36117951-82A7C771-240E-4D41-8A29-E8A1DA7508AFQ36360522-577D0DB5-D4D1-4D1C-AD59-BFBA1DDF38DEQ36511609-5E084388-BB4E-4539-A610-6F3160D968D2Q36675819-28845584-17B9-43EA-871B-0CC2C4FE61CDQ36703422-184329CC-3EC1-4284-9F9A-E1C1CA14BE4FQ36779811-FCD2D8C3-4479-4DE0-8A37-9C2469820700Q37006096-E5205A70-7886-4FAB-92B2-F3A44EE612D2Q37058023-EFDBC4C0-18D1-4B6F-8817-8E03A4F49F22Q37735891-76516FB3-3382-4164-8B91-C3AF3C94AEDBQ38167693-F9A677B0-D170-4E63-A57C-B47C6B90DA4CQ42858221-E7A7D470-FEE3-4411-82E5-88095B3738E4Q42954210-9B59ACC6-3A3E-46E6-987B-F47AF2FB6E74Q43135387-DFD87DFF-22B1-40BB-8D27-CE21EC398E5CQ43194874-08A36910-6ACC-4975-8770-69FE6AE5D1F8Q43280664-D54CFE17-7AE0-4BEC-B1F5-C71AF5ACD76DQ45056140-414F2516-4B3D-4DDE-8ED8-58AECD07F79CQ45280745-28067814-9119-46E5-BCCC-B23E53BE01D1Q46147161-281B3952-495B-4566-8FA0-330809F68416Q48354308-D75BBFDE-F6B8-44C6-A296-6D016BBE885E
P2860
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Newer hypnotic drugs for the s ...... eview and economic evaluation.
@ast
Newer hypnotic drugs for the s ...... eview and economic evaluation.
@en
type
label
Newer hypnotic drugs for the s ...... eview and economic evaluation.
@ast
Newer hypnotic drugs for the s ...... eview and economic evaluation.
@en
prefLabel
Newer hypnotic drugs for the s ...... eview and economic evaluation.
@ast
Newer hypnotic drugs for the s ...... eview and economic evaluation.
@en
P2093
P356
P1476
Newer hypnotic drugs for the s ...... eview and economic evaluation.
@en
P2093
P304
iii-x, 1-125
P356
10.3310/HTA8240
P577
2004-06-01T00:00:00Z